Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Zeier

Showing results (141-150 of 382) with videos related to

Pageof 39
Sort By:
Clinical Transplantation|June 6, 2017
Switch to an everolimus-facilitated cyclosporine A sparing immunosuppression improves glycemic control in selected kidney transplant recipientsFlorian Kälble, Jörg Seckinger, Matthias Schaier, et al.
Critical Care (London, England)|August 6, 2020
Plasma exchange in critically ill COVID-19 patientsChristian Morath, Markus A Weigand, Martin Zeier, et al.
BMC Immunology|October 8, 2016
IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipientsMahmoud Sadeghi, Imad Lahdou, Gerhard Opelz, et al.
Transplant Immunology|October 2, 2012
Methylprednisolone treatment increases the proportion of the highly suppressive HLA-DR(+)-Treg-cells in transplanted patientsNicole Seissler, Edgar Schmitt, Friederike Hug, et al.
Plos One|April 4, 2012
DR(high+)CD45RA(-)-Tregs potentially affect the suppressive activity of the total Treg pool in renal transplant patientsMatthias Schaier, Nicole Seissler, Edgar Schmitt, et al.
The Journal of Investigative Dermatology|October 21, 2011
Absence of mismatch repair deficiency-related microsatellite instability in non-melanoma skin cancerMiriam Reuschenbach, Claudia Sommerer, Wolfgang Hartschuh, et al.
Clinical Transplantation|November 21, 2009
Decreasing plasma soluble IL-1 receptor antagonist and increasing monocyte activation early post-transplant may be involved in pathogenesis of delayed graft function in renal transplant recipientsMahmoud Sadeghi, Volker Daniel, Cord Naujokat, et al.
Trials|December 16, 2014
The Calcineurin Inhibitor-Sparing (CIS) Trial - individualised calcineurin-inhibitor treatment by immunomonitoring in renal allograft recipients: protocol for a randomised controlled trialClaudia Sommerer, Matthias Schaier, Christian Morath, et al.
Clinical Transplantation|July 25, 2007
Evidence for IFN-gamma up- and IL-4 downregulation late post-transplant in patients with good kidney graft outcomeMahmoud Sadeghi, Volker Daniel, Cord Naujokat, et al.
Nephron|September 10, 2002
Cyclosporin A toxicity of the renal allograft--a late complication and potentially reversibleClaudia Sommerer, Okaf Hergesell, Anna-Maria Nahm, et al.
Pageof 39

Showing results (141-150 of 382) with videos related to

Sort By:
Pageof 39
Clinical Transplantation|June 6, 2017
Switch to an everolimus-facilitated cyclosporine A sparing immunosuppression improves glycemic control in selected kidney transplant recipientsFlorian Kälble, Jörg Seckinger, Matthias Schaier, et al.
Critical Care (London, England)|August 6, 2020
Plasma exchange in critically ill COVID-19 patientsChristian Morath, Markus A Weigand, Martin Zeier, et al.
BMC Immunology|October 8, 2016
IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipientsMahmoud Sadeghi, Imad Lahdou, Gerhard Opelz, et al.
Transplant Immunology|October 2, 2012
Methylprednisolone treatment increases the proportion of the highly suppressive HLA-DR(+)-Treg-cells in transplanted patientsNicole Seissler, Edgar Schmitt, Friederike Hug, et al.
Plos One|April 4, 2012
DR(high+)CD45RA(-)-Tregs potentially affect the suppressive activity of the total Treg pool in renal transplant patientsMatthias Schaier, Nicole Seissler, Edgar Schmitt, et al.
The Journal of Investigative Dermatology|October 21, 2011
Absence of mismatch repair deficiency-related microsatellite instability in non-melanoma skin cancerMiriam Reuschenbach, Claudia Sommerer, Wolfgang Hartschuh, et al.
Clinical Transplantation|November 21, 2009
Decreasing plasma soluble IL-1 receptor antagonist and increasing monocyte activation early post-transplant may be involved in pathogenesis of delayed graft function in renal transplant recipientsMahmoud Sadeghi, Volker Daniel, Cord Naujokat, et al.
Trials|December 16, 2014
The Calcineurin Inhibitor-Sparing (CIS) Trial - individualised calcineurin-inhibitor treatment by immunomonitoring in renal allograft recipients: protocol for a randomised controlled trialClaudia Sommerer, Matthias Schaier, Christian Morath, et al.
Clinical Transplantation|July 25, 2007
Evidence for IFN-gamma up- and IL-4 downregulation late post-transplant in patients with good kidney graft outcomeMahmoud Sadeghi, Volker Daniel, Cord Naujokat, et al.
Nephron|September 10, 2002
Cyclosporin A toxicity of the renal allograft--a late complication and potentially reversibleClaudia Sommerer, Okaf Hergesell, Anna-Maria Nahm, et al.
Pageof 39